Intracellular Activation of Bioorthogonal Nanozymes through Endosomal Proteolysis of the Protein Corona
- 28 April 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 14 (4), 4767-4773
- https://doi.org/10.1021/acsnano.0c00629
Abstract
Bioorthogonal activation of prodrugs provides a strategy for on-demand on-site production of therapeutics. Intracellular activation provides a strategy to localize therapeutics, potentially minimizing off-target effects. To this end, nanoparticles embedded with transition metal catalysts (nanozymes) were engineered to generate either "hard" irreversible or "soft" reversible coronas in serum. The hard corona induced nanozyme aggregation, effectively inhibiting nanozyme activity, whereas only modest loss of activity was observed with the nonaggregating soft corona nanozymes. In both cases complete activity was restored by treatment with proteases. Intracellular activity mirrored this reactivation: endogenous proteases in the endosome provided intracellular activation of both nanozymes. The role of intracellular proteases in nanozyme reactivation was verified through treatment of the cells with protease inhibitors, which prevented reactivation. This study demonstrates the use of intracellular proteolysis as a strategy for localization of therapeutic generation to within cells.Funding Information
- National Institute of Biomedical Imaging and Bioengineering (EB022641)
This publication has 49 references indexed in Scilit:
- A Decade of Bioorthogonal ChemistryAccounts of Chemical Research, 2011
- Labeling Live Cells by Copper-Catalyzed Alkyne−Azide Click ChemistryBioconjugate Chemistry, 2010
- What does the cell see?Nature Nanotechnology, 2009
- Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of FunctionalityAngewandte Chemie, 2009
- Nanocarriers as an emerging platform for cancer therapyNature Nanotechnology, 2007
- Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticlesProceedings of the National Academy of Sciences of the United States of America, 2007
- Ruthenium‐Induced Allylcarbamate Cleavage in Living CellsAngewandte Chemie, 2006
- “Cleaning” of nanoparticle inhibitors via proteolysis of adsorbed proteinsChemical Communications, 2006
- Chemistry in living systemsNature Chemical Biology, 2005
- Control of Protein Structure and Function through Surface Recognition by Tailored Nanoparticle ScaffoldsJournal of the American Chemical Society, 2004